Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
Cancer Discovery
|
August 7, 2014
Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma
Eliezer M Van Allen, Kent W Mouw, Philip Kim, et al.
Nature Communications
|
April 26, 2020
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
Kwanghee Kim, Wenhuo Hu, François Audenet, et al.
Advances in Anatomic Pathology
|
June 15, 2021
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers
Eva Compérat, Mahul B Amin, Jonathan I Epstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
Gopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.
European Urology
|
November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma
Kwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
European Urology
|
September 26, 2025
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort
Viranda H Jayalath, Melissa Assel, Gopa Iyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma
Jonathan A Coleman, Wesley Yip, Nathan C Wong, et al.
Advances in Anatomic Pathology
|
June 15, 2021
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia
Mahul B Amin, Eva Comperat, Jonathan I Epstein, et al.
JCO Precision Oncology
|
May 1, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer
Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
Cancer Discovery
|
August 7, 2014
Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma
Eliezer M Van Allen, Kent W Mouw, Philip Kim, et al.
Nature Communications
|
April 26, 2020
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
Kwanghee Kim, Wenhuo Hu, François Audenet, et al.
Advances in Anatomic Pathology
|
June 15, 2021
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers
Eva Compérat, Mahul B Amin, Jonathan I Epstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
Gopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.
European Urology
|
November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma
Kwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
European Urology
|
September 26, 2025
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort
Viranda H Jayalath, Melissa Assel, Gopa Iyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma
Jonathan A Coleman, Wesley Yip, Nathan C Wong, et al.
Advances in Anatomic Pathology
|
June 15, 2021
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia
Mahul B Amin, Eva Comperat, Jonathan I Epstein, et al.
JCO Precision Oncology
|
May 1, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer
Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran, et al.
Page
of 14